Moreover, pancreatic cancer patients were observed to have increased levels of PD-L1 and galectin 9 in circulating γδ T cells, with even higher levels in tumor-infiltrating γδ T cells, compared to healthy individuals [1, 119]. This evidence concerns the gene LGALS9 and pancreatic neoplasm.